R&D for Neglected Diseases
In recent years neglected diseases attracted much attention. In particular, a debate has developed on which incentive scheme could be more effective to stimulate R&D investments, by pharmaceutical companies, to treat such diseases. The debate took place in conferences, academic journals, reports and other arenas, and mostly focused on the merits and limitations of push, pulls and mixed push-pull, incentives. Taking this widely spread debate as a starting point, within a stylized economic model this work compares the strenght of alternative incentive schemes for inducing R&D investments. The model is a contribution to shed light on the key forces driving R&D decisions. Under the assumption of expected profit maximizing firms, the main message of the paper is that co-funding incentive schemes appear to be stronger incentives, than constant-sum schemes, in inducing firms R&D effort.
|Date of creation:||Jun 2012|
|Contact details of provider:|| Postal: P.O. Box 1203, 6201 BE Maastricht|
Phone: +31 43 387 08 08
Fax: +31 43 387 08 00
Web page: http://research.msm.nl
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Konrad, Kai A., 2009. "Strategy and Dynamics in Contests," OUP Catalogue, Oxford University Press, number 9780199549603, December.
When requesting a correction, please mention this item's handle: RePEc:msm:wpaper:2012/07. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Maud de By)
If references are entirely missing, you can add them using this form.